Neuroendocrine Tumor

Excited to see the latest @charlesrudin lab paper published in @ScienceTM: "Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers". #lungcancer #prostatecancer #SCLC #lineageplasticity https://t.co/sKHYNaave7 (@AlvaroQuintanal)

That's true if the system was all based on CEA, that in fact commonly it's not. One can be more prone to uptake low-value higher cost/QALY when the tailored pop is tiny (late line SCLC), because budget impact eventually matters on how you break down recources. (@darioT_)

Looking to learn about the latest developments in understanding #SCLC biology, relevant subtypes & clinical trials? Watch this new #MedEd video produced with @LUNGevity and featuring @teekayowo, @LealTiciana, & Dr. Carl Gay https://t.co/9hoGbxKPOa #ASCO23 (@PeerView)

Part 2 of 2 How can radiopharmaceuticals be best used in the management of adult solid tumours? Join @drjasonstarr Prof. Jorge Garcia and @ErikMittraMD as they share their insights. Watch now: https://t.co/1muW0TcjaM #Oncology #Radiopharmaceuticals #ProstateCancer #GEPNETs (@touchONCOLOGY)

Part 2 of 2 How can radiopharmaceuticals be best used in the management of adult solid tumours? Join @drjasonstarr Prof. Jorge Garcia & @ErikMittraMD as they share their insights. Watch now: https://t.co/g2F4YA0zw7 #Endocrinology #Radiopharmaceuticals #ProstateCancer #GEPNETs (@touchENDOCRINE)

A new study led by @PamelaKunzMD explores the sex & gender differences in the epidemiology, treatment-related adverse effects & outcomes of neuroendocrine neoplasm (NEN), cancer typically found in the GI tract. Read more. @YaleMed @YaleCancer @WHRYale https://t.co/zK16TnVJJC (@YaleIMed)

Thanks Celina; my first thought is paraganglioma. (@dinesh_rakheja)

Bazı kanserler çok hızlı yayılıyor. SCLC çok agresif. Hızlı şekilde extended evreye geçiliyor. Hastaların çoğu belirti farkettiginde son aşamada oluyor. Ayrıca covid kanser metastazını artıyor muhtemelen. Hocamız daha doğru bilgi verir. (@stocktr2022)

Agree - for AML, SCLC, pancreas, GBM, other aggressive diseases, no need for a surrogate endpoint when using the harder-to-fudge OS is reasonable (@Eddie_Cliff)

También publicamos la segunda parte de las guías mexicanas para el tratamiento del cáncer de pulmón de células pequeñas #SCLC #GAMO #SMEO #MJO @incanMX @SMEOMX @Tu_IMSS @ISSSTE_mx @HemOncINCMNSZ https://t.co/vvUOr7gRls (@EnriqueSoto8)

Fantastic review and updates on SCLC. Congratulations to all co-authors ! @LaurenByersMD @HeekeSimon @fred_hirsch (@BZhangMD)

What does this mean Dr Laura? Does it mean that carcinoid tumors are primary lung neoplasms? I am not into medical field Laura,just kidding...lol..But i want to learn.. (@Akatakpolikpo)

Disseminated small cell lung cancer is an extreme example. It's not as if second-line NSCLC has such a long time line that we can't get a timely answer to OS. We have erred way too much on side of surrogate endpoints giving us false signals. And those who say PFS alone should… https://t.co/NlkQ0HgocY (@JackWestMD)

It has been an honor to coordinate with Dr. @charocampelo these excellent SCLC experts to publish the new @_SEOM and @gecp_org guidelines for SCLC. New data and strategies. @Hospital_FJD @UAM_Madrid @DocenciaFJD @AEACaP @OncoAlert #LCSM #SCLC (@ManuelDomine)

@VinGuptaMD 🙏 She needs our support and your voice can make a difference! Help little Jana in her battle against Stage 4 Neuroblastoma, a rare childhood cancer. Retweet and share her story to raise awareness and funds for her treatment. https://t.co/wHnSoo6bDj (@simonaajoness)

Inova Lung Cancer Researcher Leads Study Offering New Hope for Small Cell Lung Cancer Patients - Inova Newsroom ⁦@InovaSchar⁩ ⁦@InovaHealth⁩ ⁦⁦⁦@LaurenByersMD⁩ ⁦@ReckampK⁩ ⁦@RamSubraMD⁩ ⁦@triparnasen⁩ https://t.co/B8bIrtmmUL (@NaglaAKarimMD)

Coming soon - my conversation with Dr. @christine_lovly and Dr. Smruthy Sivakumar about this brilliant analysis on #SCLC. Stay tuned to @LUNGevity for future air date! (@acmoorephd)

"To fill every moment and relationship with meaning ... and value." Words which will resonate with every Neuroendocrine Cancer patient. Thank you for sharing. (@ncukcharity)

I travel to MDA from Louisville, KY several times a year for medullary thyroid cancer monitoring and lung & breast cancer follow up. MDA is the most amazing place. I couldn’t ask for a better patient experience. Job well done, Dr. Frumovitz. Sending positive vibes your way. (@gerber2012)

😨scary data on care for neuroendocrine *carcinoma*: 1️⃣ out3️⃣pts w stage 4 NEC had surgery ❓Analysis problem - misclassification ❓Misinformed care - overuse of surgery (@NANETS1 recent guidelines👇🏻) Either way, seems scary. How to do better? https://t.co/KDD3icuOYB @OncoThor… https://t.co/nzJq3ybrKY (@HalletJulie)

Excited to share our analysis of 3,600 “real world” cases of Small Cell Lung Cancer (SCLC) – @christine_lovly #cancer #brainmetastases #lungcancer #mutations #realworld #tumors #oncology #oncodaily https://t.co/ihtdnq3tie (@oncodaily)

@Katja_K_Vassi @MargaretWierma1 @LetsCureAcc @accCURE @2019_acc @AccSurvey @OncoThor @DrSukrithan @netcancerday @DianeReidyLagun @drjjhall (@JaydiDelRivero)

My husband had neuroendocrine cancer. Diagnosed in 2009, died in 2021. He had a significant deterioration of his health in late 2020, but did not want to know his prognosis or to plan. It fell to me & our daughter to have the conversations when he finally lacked capacity. So hard (@higgins_dee)

VIPoma (@DrLipman1)

Vipoma (@ElenaSophocleo5)

VIPoma (@DavidACohen3)

WDHA due to VIPoma (@Kryonknightley)

Vipoma (@Uniraopelumi)

VIPoma in the pancreatic tail! (@AhmedHalimaMD)

Vipoma مالة اهلنا Achlorhydria?! (@Hamatmat97)

Please help us help Ivana from Argentina, read her story and how to help here: https://t.co/kdhgdqiJ0b @NeuroendocrinoS @netcancerfound @JaydiDelRivero @NIH @ContraCancerEs @FEMEXER @GgnetGrupo @CecyGar61164011 @ncukcharity @FLaNETcommunity @CNETSCanada @CNETSIndia (@NETsMexico)

Watch #SCLC experts @teekayowo, @LealTiciana, & Carl M. Gay, MD, PhD, to receive nuanced guidance on how to make the most of current therapies and updates on emerging treatment strategies in this #MedEd video produced with @LUNGevity: https://t.co/9hoGbxKPOa #MedTwitter #ASCO23 (@PeerView)

🧬SKIN CANCER STUDY: @WeillCornell is now enrolling subjects in HCRN MCC20-443 "Phase II Study of PRRT with Immunotherapy for Patients with Merkel Cell Cancer (iPRRT)" @pashtoonkasi Learn more: https://t.co/kXM2vrmlVT (@hoosiercancer)

At 13 in 1981 I began my life with Neuroendocrine cancer with so little known. My brother & I inherited from our Dad. Many people say I’m strong, brave & inspiring, most days I am but 42 yrs of surgery, scans, anaesthesia, pain has been & still is tough. Sending you Love Liz xx (@MariaStamp3)

Thank you for what you do. As the spouse of a man fighting a stage4 neuroendocrine cancer of the pancreas since 2015, our oncologists have become dear friends. Chemo, SBRT, whipple surgery, scans, blood clots, and now tumors in the liver, rough road. You have a stressful job! (@crazywoman6956)

El profesor ⁦@edgardo_ny⁩ covers gaps in knowledge and new studies for locally advanced lung cancer and SCLC at Best of ⁦@ASCO⁩ Miami - safety of chemoIO w radiation and IO/IO - RT—> targeted therapies -best approaches for treating pts w poos PS #lcsm ⁦ (@Latinamd)

Paraganglioma (@grupomediconsul)

Have seen at least 3 cases of long covid that turned out to be 1. Small cell lung cancer 2. RA ILD 3. Acute eosinophilic pneumonia. All felt like they had covid, but the test came negative. But still got diagnosed with it. (@Drhtaha)

Great @SylvesterCancer Heme-Onc Grand Rounds this morning with @AmanChauhanMD -our new Neuroendocrine Tumor Program Leader #NETs #lcsm #Theragnostics (@Latinamd)

Great @SylvesterCancer Heme-Onc Grand Rounds this morning with @AmanChauhanMD -our new Neuroendocrine Tumor Program Leader #NET #lcsm (@Latinamd)

Dr. @edgardo_ny provides an update on #SCLC at the Miami Best of ASCO, outlining the current chemo-immunotherapy standard and the hope for personalized therapies. S1929 with Dr. @NaglaAKarimMD was an important proof of concept study from #ASCO23 (@StephenVLiu)

Paraganglioma (@WidedAjouli)